About this trial
The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. The team expects that after exposure to the intervention, relative to the control group, participants in the experimental condition will manifest more favorable changes in knowledge, attitudes, and behaviors of adequate care towards Latinx transmasculine and non-binary people.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Medical student currently in third year of medical school training
Disqualifiers
Do not speak English
Trial design
Parallel
Treatments tested in this trial
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module
BehavioralAn online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.
Disaster Preparedness Course
BehavioralAn online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.
Treatment groups
Trial outcomes
Primary outcomes
Change cervical cancer preventive behaviors, as determined by the Cervical Cancer Preventive Behaviors Inventory
The CCPBI includes 46 non-verbal and verbal behaviors that can be manifested during the SPS interactions with LTM. The team expects that following intervention exposure, relative to control group participants, intervention participants will manifest a higher mean number of CC preventive behaviors on the CCPBI outcome.
Change in LTMNB knowledge, as determined by Transmasculine knowledge index
This measure assesses health professionals' knowledge of TM-specific health issues. Intervention participants, relative to controls, will have a higher mean knowledge (literacy) level regarding LTM issues.
Change negative attitudes towards LTMNB, as determined by the transgender stigma scale
This scale measures stigma related to transgender identity among healthcare providers. Intervention participants, relative to controls, will have a lower mean level of stigmatizing attitudes toward LTM
Change negative and increase positive emotions related to LTMNB, as determined by the Emotional Reactions Scale
This scale measures emotional reactions to LTMNB. Intervention participants, relative to control participants, will have an increase in the mean of positive emotions, and a reduction in the mean level of negative emotions.
Secondary outcomes
Sex as a biological variable
Following NIH guidance regarding investigating differential effects of sex and gender, we will repeat all analyses twice, stratified by a) sex at birth and b) current gender identification, respectively.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ponce Medical School Foundation, Inc.
Lead sponsor
National Cancer Institute (NCI)
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
This trial is not recruiting at the moment. You can still explore other options: